Bayer gets EU backing to extend Eylea treatment gapsGerman pharmaceutical firm Bayer has received a recommendation from the European Medicines Agency (EMA) to extend dosing intervals for its anti-blindness drug…25 May 2025 · 1 MIN READ
Daily Tribune